UCLA is one of only a few programs on the West Coast to offer strong expertise in living donor kidney transplant and incompatible blood type kidney transplant.
Our team is highly experienced in innovative techniques such as kidney exchange and desensitization to make transplants more likely to succeed. Our extensive experience with adult kidney transplant and pediatric kidney transplant makes us a trusted choice for living donor kidney transplant.
Learn more about:
Incompatible Blood Type Kidney Transplant
UCLA's team includes leading experts in incompatible blood type kidney transplantation. We routinely manage blood type incompatibilities for patients of all ages.
Until recently, we could not perform a kidney transplant unless both the kidney recipient and the donor had compatible blood types. About one-third of donors and recipients were declined due to ABO blood type incompatibility.
Now, using an innovative desensitization technique, we can eliminate a recipient's reaction to an incompatible blood type. This process allows more people to receive and benefit from a living donor kidney transplant.
All people have one of four blood types: O, A, B and AB. We are all compatible with our own blood type and possibly with others:
When a patient's potential living donor has one blood type, and the patient has a different, incompatible blood type, that donor would typically be unsuitable for that patient.
Fortunately, depending on the situation, we can often turn an incompatible donor blood type into a successful transplant, using incompatible blood type transplant or other approaches, such as our Kidney Exchange Program
To prevent immediate organ rejection following ABO incompatible transplantation, our team performs a simple blood test. This test tells us how much antibody the patient has to the donor kidney's blood type.
In most cases, the level of antibody is treatable. The patient undergoes a two-step process to remove the blood group antibodies:
This process usually takes about two to three weeks. Then, when your antibodies are at an acceptable level, the transplant can be performed. Your transplant donor does not need to do anything different from any other living donor kidney transplant donor.
We continue to monitor your antibody levels after transplant. Beginning two weeks after the operation, your medications and treatment regimens are the same as for blood group compatible transplant patients.
Learn more about our patient education for all kidney transplants.
More Publications on UCLA Kidney Transplant Program: